Posterior Fossa Tumours in the First Year of Life: A Two-Centre Retrospective Study

Posterior fossa tumours (PFTs) in infants are very rare, and information on these tumours is scarce in the literature. This retrospective study reports their pathological characteristics and describes surgical aspects and treatment outcomes. A two-centre cohort of infants with PFTs treated from 2007 to 2018 was retrospectively reviewed. Patient characteristics, clinical, and treatment data were reviewed. Survival curves for progression-free survival (PFS) and overall survival (OS) were generated. Thirty-three infants were retrieved. There were 11 low grade and 22 high-grade tumours. The most common presenting symptom was intracranial hypertension. Fifteen children out of thirty-three progressed. Five-year PFS was significantly lower in children with high-grade tumours (38.3%) than those with low-grade tumours (69.3%), p = 0.030. High-grade pathology was the only predictor of progression (HR 3.7, 95% CI 1.1–13.31), p = 0.045. Fourteen children with high-grade tumours died, with a 5-year OS of 55.25%. PFTs in children below one year of age still represent a unique challenge. Infants with high-grade tumours display the worst outcomes and the lowest survival, indicating that more effective strategies are needed.

[1]  OUP accepted manuscript , 2022, Neuro-Oncology.

[2]  P. Grillner,et al.  Postoperative speech impairment and surgical approach to posterior fossa tumours in children: a prospective European multicentre cohort study. , 2021, The Lancet. Child & adolescent health.

[3]  H. Toledano,et al.  Postoperative hydrocephalus management may cause delays in adjuvant treatment following paediatric posterior fossa tumour resection: a multicentre retrospective observational study , 2021, Child's Nervous System.

[4]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. , 2021, Neuro-oncology.

[5]  M. Naushahi,et al.  Epidemiology of paediatric central nervous system tumours in Queensland, Australia , 2021, Journal of clinical neuroscience.

[6]  P. A. Sabancı,et al.  Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma , 2021, Child's Nervous System.

[7]  L. Massimi,et al.  Correlation between Pre- and Post-Surgical Findings for Long-Term Neurocognitive and Behaviour Development Due to Posterior Fossa Pilocytic Astrocytomas: The Trend after 10 Years , 2021, Diagnostics.

[8]  C. Cowie,et al.  A validation study of the modified Canadian Preoperative Prediction Rule for Hydrocephalus in children with posterior fossa tumors , 2021, Journal of Neurosurgery: Pediatrics.

[9]  Colette J. Shen,et al.  Radiation therapy for infants with cancer , 2021, Pediatric blood & cancer.

[10]  A. M. Caroleo,et al.  Infantile Brain Tumors: A Review of Literature and Future Perspectives , 2021, Diagnostics.

[11]  S. D'agostini,et al.  Risk Factors of Persistent Hydrocephalus in Children with Brain Tumor: A Retrospective Analysis , 2021, Pediatric Neurosurgery.

[12]  U. Löbel,et al.  A Diagnostic Algorithm for Posterior Fossa Tumors in Children: A Validation Study , 2021, American Journal of Neuroradiology.

[13]  L. Constine,et al.  Surveillance for radiation‐related late effects in childhood cancer survivors: The impact of using volumetric dosimetry , 2020, Cancer medicine.

[14]  O. Klein,et al.  Abord chirurgical de la fosse cérébrale postérieure chez l’enfant, avec considérations anesthésiques et complications : position en décubitus ventral et position assise. Note technique , 2020 .

[15]  T. Niazi,et al.  Age of diagnosis clinically differentiates atypical teratoid/rhabdoid tumors diagnosed below age of 3 years: a database study , 2020, Child's Nervous System.

[16]  D. Thompson,et al.  Fourth ventricle tumors in children: complications and influence of surgical approach. , 2020, Journal of neurosurgery. Pediatrics.

[17]  T. Jacques,et al.  Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study , 2020, The Lancet. Child & adolescent health.

[18]  Yugang Jiang,et al.  Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study , 2020, Medicine.

[19]  S. Sheth,et al.  Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location , 2020, Clinical Neurology and Neurosurgery.

[20]  S. Rossi,et al.  Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives , 2020, Diagnostics.

[21]  T. Jacques,et al.  The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second‐generation subtypes , 2020, Neuropathology and applied neurobiology.

[22]  T. Yock,et al.  Brain tumors: Medulloblastoma, ATRT, ependymoma , 2020, Pediatric blood & cancer.

[23]  F. Gilles,et al.  Excellent Outcome of Young Children with Nodular Desmoplastic Medulloblastoma Treated on "Head Start" III: A Multi-Institutional, Prospective Clinical Trial. , 2020, Neuro-oncology.

[24]  M. LoPresti,et al.  Predicting dysphagia in children undergoing surgery for posterior fossa tumors , 2020, Child's Nervous System.

[25]  Claire M. Faltermeier,et al.  Survival of infants ≤24 months of age with brain tumors: A population-based study using the SEER database , 2019, PloS one.

[26]  U. Schüller,et al.  Predictive factors associated with ventriculoperitoneal shunting after posterior fossa tumor surgery in children , 2019, Child's Nervous System.

[27]  D. Thompson,et al.  Intracranial Neoplasms in the First Year of Life: Results of a Third Cohort of Patients From a Single Institution , 2019, Neurosurgery.

[28]  C. Stiller,et al.  Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study , 2019, BMC Cancer.

[29]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.

[30]  D. Zurakowski,et al.  352 Management Strategies for Hydrocephalus in Pediatric Posterior Fossa Brain Tumor , 2018, Neurosurgery.

[31]  Á. Lassaletta,et al.  Medulloblastoma in infants: the never-ending challenge. , 2018, The Lancet. Oncology.

[32]  T. Niazi,et al.  Epidemiology and short-term surgical outcomes of children presenting with cerebellar tumors , 2018, Clinical Neurology and Neurosurgery.

[33]  M. Kirkman,et al.  Surgical decision-making in the management of childhood tumors of the CNS disseminated at presentation. , 2018, Journal of neurosurgery. Pediatrics.

[34]  F. Milisavljevic,et al.  Evaluation of clinical characteristics as indicators for shunt procedure in patients with medulloblastoma: PS210. , 2017, Porto biomedical journal.

[35]  K. Skullerud,et al.  A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood ( 16 years ) low grade glioma e A final report , 2017 .

[36]  P. Ferroli,et al.  Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma. , 2016, Neuro-oncology.

[37]  B. Orr,et al.  Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas. , 2016, Journal of neurosurgery. Pediatrics.

[38]  S. Hanaei,et al.  Brain tumors in infants , 2015, Journal of Pediatric Neurosciences.

[39]  E. Guadagno,et al.  Posterior fossa tumors in infants and neonates , 2015, Child's Nervous System.

[40]  A. Kulkarni,et al.  Functional and neuropsychological late outcomes in posterior fossa tumors in children , 2015, Child's Nervous System.

[41]  J. Riva-Cambrin,et al.  Management of posterior fossa tumors and hydrocephalus in children: a review , 2015, Child's Nervous System.

[42]  P. Lähteenmäki,et al.  Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in Finland. , 2015, Neuro-oncology.

[43]  E. Eissa,et al.  Infratentorial complications following preresection CSF diversion in children with posterior fossa tumors. , 2015, Journal of neurosurgery. Pediatrics.

[44]  C. Colosimo,et al.  MRI findings of olivary degeneration after surgery for posterior fossa tumours in children: incidence, time course and correlation with tumour grading , 2015, La radiologia medica.

[45]  H. Habib.  Intraoperative precautionary insertion of external ventricular drainage catheters in posterior fossa tumors presenting with hydrocephalus , 2014 .

[46]  R. Siebert,et al.  Feasibility of Intensive Multimodal Therapy in Infants Affected by Rhabdoid Tumors – Experience of the EU-RHAB registry , 2014, Klinische Pädiatrie.

[47]  O. Witt,et al.  High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB) , 2014, Bone Marrow Transplantation.

[48]  A. Kulkarni,et al.  Physical functioning in pediatric survivors of childhood posterior fossa brain tumors. , 2014, Neuro-oncology.

[49]  S. Kwiatkowski,et al.  Torticollis as a first sign of posterior fossa and cervical spinal cord tumors in children , 2014, Child's Nervous System.

[50]  A. Kulkarni,et al.  Long-term quality of life in children treated for posterior fossa brain tumors. , 2013, Journal of neurosurgery. Pediatrics.

[51]  J. Wellons,et al.  Validation and modification of a predictive model of postresection hydrocephalus in pediatric patients with posterior fossa tumors. , 2013, Journal of neurosurgery. Pediatrics.

[52]  M. Al-Hussaini,et al.  Central nervous system tumors in the first year of life: a clinical and pathologic experience from a single cancer center , 2013, Child's Nervous System.

[53]  M. McDonald,et al.  Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) Data. , 2012, International journal of radiation oncology, biology, physics.

[54]  S. O'Neil,et al.  Neuropsychological differences between survivors of supratentorial and infratentorial brain tumours. , 2011, Journal of intellectual disability research : JIDR.

[55]  C. Tseng,et al.  Intracranial tumors in infants: a single institution experience of 22 patients , 2011, Child's Nervous System.

[56]  G. Gustafsson,et al.  Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984–2005 , 2009, Acta paediatrica.

[57]  J. Birch,et al.  Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. , 2009, Neuro-oncology.

[58]  S. Sgouros,et al.  Neuropsychological sequelae and quality of life following treatment of posterior fossa ependymomas in children , 2009, Child's Nervous System.

[59]  M. Shamji,et al.  Intracranial tumors in first year of life: the CHEO experience , 2009, Child's Nervous System.

[60]  Eric Bouffet,et al.  Tumors of the central nervous system in the first year of life , 2007, Pediatric blood & cancer.

[61]  E. Helseth,et al.  Management of Hydrocephalus in Children with Posterior Fossa Tumors: Role of Tumor Surgery , 2007, Pediatric Neurosurgery.

[62]  G. Cinalli,et al.  Endoscopic third ventriculostomy in the treatment of hydrocephalus in posterior fossa tumors in children , 2004, Child's Nervous System.

[63]  A. Medina-Sansón,et al.  Brain tumors in children under 1 year of age: emphasis on the relationship of prognostic factors , 2003, Child's Nervous System.

[64]  P. Duffner.  Brain tumors in children under 1 year of age: emphasis on the relationship of prognostic factors , 2003, Child's Nervous System.

[65]  W. Maixner,et al.  Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. , 1999, Journal of neurosurgery.

[66]  E. Boltshauser,et al.  [Brain tumors in infants]. , 1990, Klinische Pädiatrie.